Melanoma
Commentary
Skin Cancer Screening and Prevention During the COVID-19 Pandemic
It is important for dermatologists to maintain skin cancer screening and prevention efforts during the coronavirus disease 2019 pandemic.
Military Dermatology
Skin Cancer in the US Military
This review proposes education of individual military servicemembers regarding skin cancer prevention and identification, increasing the...
Article
How should we evaluate the benefit of immunotherapy combinations?
From the Journals
Phase 1 study: Beta-blocker may improve melanoma treatment response
“It’s exciting that an extremely inexpensive drug like propranolol that could be used in every country around the world could have an impact on...
Original Research
Mobile Apps for Professional Dermatology Education: An Objective Review
Mobile applications (apps) are a convenient way to learn dermatology, but there is no objective method to assess their quality. To determine which...
Original Research
Reliability of Biopsy Margin Status for Basal Cell Carcinoma: A Retrospective Study
The authors examined basal cell carcinoma biopsy specimens initially determined to have negative margins after routine sectioning and re-evaluated...
Conference Coverage
‘Impressive’ results with neoadjuvant T-VEC in advanced melanoma
Superior outcomes with intralesional T-VEC plus surgery persisted at 3 years.
Conference Coverage
Daily sunscreen use will prevent more melanoma deaths than early detection
“Prevention is low cost, low risk, and effective.”
Case Letter
Multiple Glomangiomas in a Patient With a History of Metastatic Melanoma
In patients with a recent history of malignancy, multiple glomangiomas may mimic cutaneous metastases. Therefore, multiple biopsies and histologic...
Conference Coverage
Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest
Cancer patients treated with immune checkpoint inhibitors are not significantly more likely to develop or die from COVID-19, two studies suggest...
Conference Coverage
Neoadjuvant immunotherapy combo produces high response rate in melanoma